In the case of AD, miR-124, besides influencing the microglia activation state, prevents Aβ production, while reducing tau phosphorylation and synaptic loss, thus having potential as a treatment strategy in AD (Zhao et al., 2021). Here, MAPT is linked to Alzheimer disease.